Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardium

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 487-499

  Boontje, Nicky M ^a   Merkus, Daphne ^b   Zaremba, Ruud ^a   Versteilen, Amanda ^a   de Waard, Monique C ^b   Mearini, Giulia ^c   de Beer, Vincent J ^b   Carrier, Lucie ^c,d,e   Walker, Lori A ^f   Niessen, Hans W M ^g   Dobrev, Dobromir ^h   Stienen, Ger J M ^a   Duncker, Dirk J ^b   Van der Velden, Jolanda ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Sorbonne Université   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY OF COLORADO   (United States)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Adrenergic stimulation; Ca2+ dependent calmodulin kinase II; Contractility; Myocardial infarction; Phosphorylation

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II GAMMA C; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOBUTAMINE; MYOSIN BINDING PROTEIN C; SERINE; THREONINE; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; MYOCARDIAL DISEASE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; ANIMALS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARRIER PROTEINS; CATECHOLAMINES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOBUTAMINE; FEMALE; HEART VENTRICLES; MALE; MICROFILAMENTS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, BETA; SWINE; TROPONIN I; VENTRICULAR REMODELING;

SUIDAE;

EID: 79551583334     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.12.002     Document Type: Article

References (41)

1. Kannel W.B. Incidence and epidemiology of heart failure. Heart Fail Rev 2000, 5:167-173.
2. Fang J., Mensah G.A., Croft J.B., Keenan N. Heart failure-related hospitalization in the U.S., 1979-2004. J Am Coll Cardiol 2008, 52:428-434.
3. Katz A.M. Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle. Part I. Heart failure as a disorder of the cardiac pump. J Card Fail 1997, 3:319-334.
4. Litwin S.E., Katz S.E., Morgan J.P., Douglas P.S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994, 89:345-354.
5. Van der Velden J., Merkus D., Klarenbeek B.R., James A.T., Boontje N.M., Dekkers D.H., et al. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res 2004, 95:e85-e95.
6. Belin R.J., Sumandea M.P., Kobayashi T., Walker L.A., Rundell V.L., Urboniene D., et al. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol 2006, 291:H2344-H2353.
7. Daniels M.C., Naya T., Rundell V.L., de Tombe P.P. Development of contractile dysfunction in rat heart failure: hierarchy of cellular events. Am J Physiol Regul Integr Comp Physiol 2007, 293:R284-R292.
8. De Waard M.C., van der Velden J., Bito V., Ozdemir S., Biesmans L., Boontje N.M., et al. Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circ Res 2007, 100:1079-1088.
9. Belin R.J., Sumandea M.P., Allen E.J., Schoenfelt K., Wang H., Solaro R.J., et al. Augmented protein kinase C-α-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res 2007, 101:195-204.
10. Duncker D.J., Boontje N.M., Merkus D., Versteilen A., Krysiak J., Mearini G., et al. Prevention of myofilament dysfunction by beta-blocker therapy in post-infarct remodeling. Circ Heart Fail 2009, 2:233-242.
11. 2+-sensitivity in heart failure: increased or decreased. J Mol Cell Cardiol 2008, 45:603-607.
12. Bristow M.R. Why does the myocardium fail? Insights from basic science. Lancet 1998, 352(Suppl 1):SI8-SI14.
13. Leosco D., Rengo G., Iaccarino G., Golino L., Marchese M., Fortunato F., et al. Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. Cardiovasc Res 2008, 78:385-394.
14. De Waard M.C., van der Velden J., Boontje N.M., Dekkers D.H.W., van Haperen R., Kuster D., et al. Detrimental effect of combined exercise training and eNOS-overexpression on cardiac function after myocardial infarction. Am J Physiol Heart Circ Physiol 2009, 296:H1513-H1523.
15. Solaro R.J., Moir A.J., Perry S.V. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature 1976, 262:615-617.
16. Buss J.E., Stull J.T. Calcium binding to cardiac troponin and the effect of cyclic AMP-dependent protein kinase. FEBS Lett 1977, 75:101-104.
17. Jeacocke S.A., England P.J. Phosphorylation of a myofibrillar protein of Mw 150, 000 in perfused rat heart, and the tentative identification of this as C-protein. FEBS Lett 1980, 122:129-132.
18. Van Kats J.P., Duncker D.J., Haitsma D.B., Schuijt M.P., Niebuur R., Stubenitsky R., et al. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 2000, 102:1556-1563.
19. Van der Velden J., Klein L.J., van der Bijl M., Huybregts M.A.J.M., Stooker W., Witkop J., et al. Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue. Cardiovasc Res 1998, 38:414-423.
20. 2+-sensitivity of force is enhanced in failing human hearts. Cardiovasc Res 2003, 57:505-514.
21. Zaremba R., Merkus D., Lamers J.M.J., Paulus W.J., dos Remedios C., Duncker D.J., et al. Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl 2007, 1:1285-1290.
22. 2+-calmodulin-dependent protein kinases. J Biol Chem 1984, 259:15587-15596.
23. Gautel M., Zuffardi O., Freiburg A., Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?. EMBO J 1995, 14:1952-1960.
24. Yuan C., Guo Y., Ravi R., Przyklenk K., Shilkofski N., Diez R., et al. Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts. Evidence for novel phosphorylation sites. Proteomics 2006, 6:4176-4186.
25. Eβ-ARmouche A., Pohlmann L., Schlossarek S., Starbatty J., Yeh Y.H., Nattel S., et al. Decreased phosphorylation levels of cardiac myosin binding protein-C in human and experimental heart failure. J Mol Cell Cardiol 2007, 43:223-229.
26. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
27. Prutz W.A. Inhibition of DNA-ethidium bromide intercalation due to free radical attack upon DNA. I. Comparison of the effects of various radicals. Radiat Environ Biophys 1984, 23:1-6.
28. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res 1999, 84:713-721.
29. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Cardiovasc Res 1999, 42:254-261.
30. 2+/calmodulin kinase II. J Clin Invest 2003, 111:617-625.
31. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005, 11:409-417.
32. Scruggs S.B., Hinken A.C., Thawornkaiwong A., Robbins J., Walker L.A., de Tombe P.P., et al. Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation. J Biol Chem 2009, 284:5097-5106.
33. McClellan G., Kulikovskaya I., Winegrad S. Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C. Biophys J 2001, 81:1083-1092.
34. Tong C.W., Gaffin R.D., Zawieja D.C., Muthuchamy M. Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics. J Physiol 2004, 558:927-941.
35. Zhang R., Zhao J., Mandveno A., Potter J.D. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 1995, 76:1028-1035.
36. Kentish J.C., McCloskey D.T., Layland J., Palmer S., Leiden J.M., Martin A.F., et al. Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 2001, 88:1059-1065.
37. Cazorla O., Szilagyi S., Vignier N., Salazar G., Krämer E., Vassort G., et al. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res 2006, 69:370-380.
38. Sweeney H.L., Stull J.T. Phosphorylation of myosin in permeabilized mammalian cardiac and skeletal muscle cells. Am J Physiol 1986, 250:C657-C660.
39. 2+-sensitivity in human myocardium depends on the phosphorylation background. J Mol Cell Cardiol 2010, 48:954-963.
40. Van Dijk S.J., Dooijes D., dos Remedios C., Michels M., Winegrad S., Lamers J.M.J., et al. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation and cardiomyocyte dysfunction. Circulation 2009, 119:1473-1483.
41. Boontje N.M., Danser A.J., Merkus D., Stienen G.J.M., Duncker D.J., van der Velden J. Myofilament dysfunction is prevented by beta-blocker therapy, but not by renin-angiotensin blockade in post-infarct remodeled myocardium. J Muscle Res Cell Motil 2008, 29:297. (Abstract).